PharmaCorp Rx Inc. (TSXV:PCRX)
Canada · Delayed Price · Currency is CAD 0.3950
0.00 (0.00%)
Nov 9, 2026, 4:00 PM EST
PharmaCorp Rx Earnings Call Transcripts
Fiscal Year 2026
-
A 3,000+ store sourcing network supports selective pharmacy acquisitions at a 6x normalized EBITDA multiple. Management targets cumulative normalized EBITDA gains of 7.5%-15% in the first three years and cited EBITDA-to-free-cash-flow conversion above 70%.
-
At the 2026 Bloom Burton Healthcare Investor Conference, a pharmacy roll-up firm detailed its exclusive acquisition pipeline, flexible exit options for owners, and focus on operational stability and top-line growth. Recent capital raised will fund further expansion and team growth.